2429913-18-6

2429913-18-6 structure

2429913-18-6 structure

Name: Clesrovimab
Chemical Name: Clesrovimab
CAS Number: 2429913-18-6
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Anti-infection RSV
Create Date: 2023-01-26 23:45:54
Modify Date: 2024-01-17 13:01:41
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection[1][2].

Name	Clesrovimab

Description	Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> RSV
References	[1]. Qiu X, et al. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53. [2]. Odumade OA, et al. Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection. Clin Infect Dis. 2022 Aug 15;75(Supplement_1):S130-S135.

No Any Chemical & Physical Properties